Abstract
We have recently shown that tumor cell proliferation, survival and drug-resistance in multiple myeloma (MM) and a broad range of other tumors is critically influenced by insulin-like growth factors (IGFs) and their receptor (IGF-1R) (
Cancer Cell
2004
;5
:221
–30Author notes
Corresponding author
2005, The American Society of Hematology
2004